Key Market Indicators
Sales of analgesic medicines in Norway are expected to reach $187 million by 2026. In 2021, the market was valued at $180 million. This represents a 0.8% annual growth rate since 2007. Norway was the ninth-largest market for analgesic medicines in 2021, behind Sweden ($180 million). Spain, Canada and Italy ranked second, third and fourth, respectively.
